Immedica Pharma AB – Trademark Portfolio
Entity Type: 09
Immedica Pharma AB holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 4 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include LOARGYS, IMMEDICA, and THINK ARGININE.
Norrtullsgatan 15
SE-113 29 Stockholm
Showing of trademarks Trademarks
Trademark Classifications
Immedica Pharma AB's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Immedica Pharma AB have?
Immedica Pharma AB has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 abandoned.
What trademark classes does Immedica Pharma AB file in?
Immedica Pharma AB files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 35 (Advertising & Business), Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Immedica Pharma AB's most well-known trademarks?
Immedica Pharma AB's registered trademark portfolio includes well-known marks such as LOARGYS, IMMEDICA, and THINK ARGININE. These are among 3 currently registered trademarks in the portfolio.
What is Immedica Pharma AB's trademark registration success rate?
Immedica Pharma AB has a 60% trademark registration rate, with 3 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.